nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—HTR2C—bipolar disorder	0.339	0.406	CbGaD
Fluoxetine—SLC6A4—bipolar disorder	0.281	0.336	CbGaD
Fluoxetine—HTR2A—bipolar disorder	0.216	0.258	CbGaD
Fluoxetine—SLC6A2—locus ceruleus—bipolar disorder	0.00995	0.112	CbGeAlD
Fluoxetine—ORM1—saliva—bipolar disorder	0.00689	0.0775	CbGeAlD
Fluoxetine—HTR2A—locus ceruleus—bipolar disorder	0.00598	0.0673	CbGeAlD
Fluoxetine—HTR2C—telencephalic ventricle—bipolar disorder	0.00565	0.0636	CbGeAlD
Fluoxetine—SLC6A2—autonomic nervous system—bipolar disorder	0.00529	0.0595	CbGeAlD
Fluoxetine—CYP2C19—urine—bipolar disorder	0.00406	0.0456	CbGeAlD
Fluoxetine—CYP1A2—urine—bipolar disorder	0.00331	0.0373	CbGeAlD
Fluoxetine—HTR2A—autonomic nervous system—bipolar disorder	0.00318	0.0358	CbGeAlD
Fluoxetine—CYP2C9—urine—bipolar disorder	0.00314	0.0354	CbGeAlD
Fluoxetine—HTR2A—telencephalic ventricle—bipolar disorder	0.00284	0.0319	CbGeAlD
Fluoxetine—HTR2A—urine—bipolar disorder	0.00259	0.0291	CbGeAlD
Fluoxetine—SLC6A4—blood plasma—bipolar disorder	0.00255	0.0287	CbGeAlD
Fluoxetine—CYP3A4—urine—bipolar disorder	0.0024	0.027	CbGeAlD
Fluoxetine—CYP2D6—urine—bipolar disorder	0.00236	0.0266	CbGeAlD
Fluoxetine—CYP2C19—blood plasma—bipolar disorder	0.00212	0.0238	CbGeAlD
Fluoxetine—CYP1A2—blood plasma—bipolar disorder	0.00173	0.0195	CbGeAlD
Fluoxetine—CYP3A5—blood plasma—bipolar disorder	0.00167	0.0188	CbGeAlD
Fluoxetine—CYP2B6—blood plasma—bipolar disorder	0.00166	0.0186	CbGeAlD
Fluoxetine—CYP2C9—blood plasma—bipolar disorder	0.00164	0.0185	CbGeAlD
Fluoxetine—HTR2A—blood plasma—bipolar disorder	0.00135	0.0152	CbGeAlD
Fluoxetine—SIGMAR1—adrenal cortex—bipolar disorder	0.00129	0.0145	CbGeAlD
Fluoxetine—Orphenadrine—GRIN1—bipolar disorder	0.00127	0.219	CrCbGaD
Fluoxetine—CYP3A4—blood plasma—bipolar disorder	0.00125	0.0141	CbGeAlD
Fluoxetine—CYP2D6—blood plasma—bipolar disorder	0.00123	0.0139	CbGeAlD
Fluoxetine—Duloxetine—SLC6A3—bipolar disorder	0.000919	0.159	CrCbGaD
Fluoxetine—SIGMAR1—thyroid gland—bipolar disorder	0.000897	0.0101	CbGeAlD
Fluoxetine—ORM1—nervous system—bipolar disorder	0.000892	0.01	CbGeAlD
Fluoxetine—ABCB1—blood plasma—bipolar disorder	0.000886	0.00997	CbGeAlD
Fluoxetine—CYP2B6—adrenal cortex—bipolar disorder	0.000841	0.00947	CbGeAlD
Fluoxetine—Duloxetine—HTR2C—bipolar disorder	0.000829	0.143	CrCbGaD
Fluoxetine—HTR2C—nervous system—bipolar disorder	0.000801	0.00902	CbGeAlD
Fluoxetine—SLC6A4—nervous system—bipolar disorder	0.00076	0.00855	CbGeAlD
Fluoxetine—SIGMAR1—cerebellum—bipolar disorder	0.00071	0.00799	CbGeAlD
Fluoxetine—Duloxetine—SLC6A4—bipolar disorder	0.000687	0.119	CrCbGaD
Fluoxetine—SLC6A2—nervous system—bipolar disorder	0.000669	0.00753	CbGeAlD
Fluoxetine—HTR2C—brain—bipolar disorder	0.000613	0.00689	CbGeAlD
Fluoxetine—CYP1A2—thyroid gland—bipolar disorder	0.000611	0.00688	CbGeAlD
Fluoxetine—ALB—brain—bipolar disorder	0.000598	0.00672	CbGeAlD
Fluoxetine—SLC6A4—brain—bipolar disorder	0.000581	0.00653	CbGeAlD
Fluoxetine—SIGMAR1—brain—bipolar disorder	0.000577	0.00649	CbGeAlD
Fluoxetine—Duloxetine—HTR2A—bipolar disorder	0.000528	0.0913	CrCbGaD
Fluoxetine—SLC6A2—brain—bipolar disorder	0.000511	0.00575	CbGeAlD
Fluoxetine—CYP2B6—nervous system—bipolar disorder	0.000493	0.00555	CbGeAlD
Fluoxetine—Atomoxetine—SLC6A3—bipolar disorder	0.000481	0.0833	CrCbGaD
Fluoxetine—ABCB1—adrenal cortex—bipolar disorder	0.00045	0.00506	CbGeAlD
Fluoxetine—Atomoxetine—HTR2C—bipolar disorder	0.000434	0.0751	CrCbGaD
Fluoxetine—HTR2A—nervous system—bipolar disorder	0.000402	0.00452	CbGeAlD
Fluoxetine—HTR2A—cerebellum—bipolar disorder	0.000378	0.00426	CbGeAlD
Fluoxetine—CYP2B6—brain—bipolar disorder	0.000377	0.00424	CbGeAlD
Fluoxetine—CYP3A4—nervous system—bipolar disorder	0.000372	0.00419	CbGeAlD
Fluoxetine—CYP2D6—nervous system—bipolar disorder	0.000366	0.00412	CbGeAlD
Fluoxetine—Atomoxetine—SLC6A4—bipolar disorder	0.00036	0.0623	CrCbGaD
Fluoxetine—CYP2D6—cerebellum—bipolar disorder	0.000345	0.00388	CbGeAlD
Fluoxetine—ABCB1—thyroid gland—bipolar disorder	0.000313	0.00352	CbGeAlD
Fluoxetine—HTR2A—brain—bipolar disorder	0.000307	0.00346	CbGeAlD
Fluoxetine—CYP2D6—brain—bipolar disorder	0.00028	0.00315	CbGeAlD
Fluoxetine—Atomoxetine—HTR2A—bipolar disorder	0.000277	0.0478	CrCbGaD
Fluoxetine—ABCB1—nervous system—bipolar disorder	0.000263	0.00296	CbGeAlD
Fluoxetine—ABCB1—cerebellum—bipolar disorder	0.000248	0.00279	CbGeAlD
Fluoxetine—ABCB1—brain—bipolar disorder	0.000201	0.00227	CbGeAlD
Fluoxetine—CYP2B6—Metabolism—NCAN—bipolar disorder	3.01e-05	0.000438	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—DRD4—bipolar disorder	2.98e-05	0.000434	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—IMPA1—bipolar disorder	2.95e-05	0.00043	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—AKR1C4—bipolar disorder	2.95e-05	0.000429	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—SLC5A3—bipolar disorder	2.95e-05	0.000429	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—NCAN—bipolar disorder	2.94e-05	0.000428	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—DRD3—bipolar disorder	2.94e-05	0.000428	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—IMPA1—bipolar disorder	2.93e-05	0.000427	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD5—bipolar disorder	2.89e-05	0.000421	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—SLC5A3—bipolar disorder	2.88e-05	0.000419	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	2.86e-05	0.000417	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—IMPA2—bipolar disorder	2.86e-05	0.000416	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—HTR1A—bipolar disorder	2.85e-05	0.000415	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—DRD4—bipolar disorder	2.85e-05	0.000415	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RGS4—bipolar disorder	2.83e-05	0.000413	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	2.82e-05	0.00041	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—TAC1—bipolar disorder	2.81e-05	0.000409	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—ADCY2—bipolar disorder	2.81e-05	0.000409	CbGpPWpGaD
Fluoxetine—CYP1A2—Biological oxidations—POMC—bipolar disorder	2.8e-05	0.000408	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—DRD2—bipolar disorder	2.78e-05	0.000405	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—DRD1—bipolar disorder	2.75e-05	0.000401	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—HTR2C—bipolar disorder	2.75e-05	0.000401	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—NDUFV2—bipolar disorder	2.73e-05	0.000398	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—ADCY2—bipolar disorder	2.68e-05	0.000391	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—DRD3—bipolar disorder	2.67e-05	0.000388	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—NDUFV2—bipolar disorder	2.67e-05	0.000388	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	2.66e-05	0.000387	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—DRD2—bipolar disorder	2.66e-05	0.000387	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—NR1D1—bipolar disorder	2.65e-05	0.000385	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—AKR1C4—bipolar disorder	2.64e-05	0.000385	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—ADCY2—bipolar disorder	2.64e-05	0.000384	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—POMC—bipolar disorder	2.63e-05	0.000383	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—DRD4—bipolar disorder	2.59e-05	0.000377	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—AKR1C4—bipolar disorder	2.58e-05	0.000376	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—NCAN—bipolar disorder	2.53e-05	0.000369	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TRPC3—bipolar disorder	2.52e-05	0.000367	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—NDUFV2—bipolar disorder	2.51e-05	0.000366	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—IMPA1—bipolar disorder	2.5e-05	0.000364	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—NDUFV2—bipolar disorder	2.49e-05	0.000363	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—SLC5A3—bipolar disorder	2.48e-05	0.000361	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	2.45e-05	0.000356	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—ADCY2—bipolar disorder	2.44e-05	0.000355	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—AKR1C4—bipolar disorder	2.43e-05	0.000354	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—DRD2—bipolar disorder	2.41e-05	0.000351	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—AKR1C4—bipolar disorder	2.41e-05	0.000351	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ADM—bipolar disorder	2.4e-05	0.00035	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—NR1D1—bipolar disorder	2.38e-05	0.000346	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TSHB—bipolar disorder	2.34e-05	0.000341	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PDE4B—bipolar disorder	2.34e-05	0.000341	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TACR1—bipolar disorder	2.34e-05	0.000341	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	2.33e-05	0.000339	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—NR1D1—bipolar disorder	2.32e-05	0.000338	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	2.31e-05	0.000337	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—NCAN—bipolar disorder	2.27e-05	0.000331	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—SLC5A3—bipolar disorder	2.23e-05	0.000324	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—NCAN—bipolar disorder	2.22e-05	0.000323	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TRPC3—bipolar disorder	2.19e-05	0.000319	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—NR1D1—bipolar disorder	2.18e-05	0.000318	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—SLC5A3—bipolar disorder	2.17e-05	0.000316	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—NR1D1—bipolar disorder	2.17e-05	0.000315	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—POMC—bipolar disorder	2.16e-05	0.000315	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—HTR2A—bipolar disorder	2.14e-05	0.000312	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CLOCK—bipolar disorder	2.13e-05	0.00031	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NDUFV2—bipolar disorder	2.13e-05	0.00031	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—NCAN—bipolar disorder	2.09e-05	0.000304	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ADM—bipolar disorder	2.09e-05	0.000304	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CLOCK—bipolar disorder	2.08e-05	0.000303	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—TPH2—bipolar disorder	2.08e-05	0.000302	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—TSHB—bipolar disorder	2.08e-05	0.000302	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CACNB2—bipolar disorder	2.08e-05	0.000302	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—NCAN—bipolar disorder	2.07e-05	0.000302	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—AKR1C4—bipolar disorder	2.06e-05	0.0003	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	2.05e-05	0.000298	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—DPYD—bipolar disorder	2.04e-05	0.000297	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PDE4B—bipolar disorder	2.03e-05	0.000296	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TSHB—bipolar disorder	2.03e-05	0.000296	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TACR1—bipolar disorder	2.03e-05	0.000296	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—SLC5A3—bipolar disorder	2.03e-05	0.000296	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CACNB2—bipolar disorder	2.03e-05	0.000295	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—TSHB—bipolar disorder	2.03e-05	0.000295	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—TPH2—bipolar disorder	2.03e-05	0.000295	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—DPYD—bipolar disorder	2e-05	0.000291	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	1.95e-05	0.000283	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	1.94e-05	0.000282	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—IMPA1—bipolar disorder	1.93e-05	0.000281	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TAC1—bipolar disorder	1.91e-05	0.000278	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CACNA1C—bipolar disorder	1.9e-05	0.000276	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—DRD1—bipolar disorder	1.87e-05	0.000273	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CACNA1C—bipolar disorder	1.86e-05	0.00027	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NR1D1—bipolar disorder	1.85e-05	0.00027	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PIK3C2A—bipolar disorder	1.85e-05	0.000269	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	1.82e-05	0.000265	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—DRD3—bipolar disorder	1.81e-05	0.000264	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PIK3C2A—bipolar disorder	1.81e-05	0.000263	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	1.81e-05	0.000263	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CLOCK—bipolar disorder	1.79e-05	0.000261	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NCAN—bipolar disorder	1.77e-05	0.000258	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—DRD4—bipolar disorder	1.76e-05	0.000257	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—TSHB—bipolar disorder	1.75e-05	0.000254	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—TPH2—bipolar disorder	1.75e-05	0.000254	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CACNB2—bipolar disorder	1.75e-05	0.000254	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—SLC5A3—bipolar disorder	1.73e-05	0.000253	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—DPYD—bipolar disorder	1.72e-05	0.00025	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	1.71e-05	0.000249	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	1.68e-05	0.000245	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—SNAP25—bipolar disorder	1.66e-05	0.000242	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TAC1—bipolar disorder	1.66e-05	0.000242	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	1.66e-05	0.000241	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	1.65e-05	0.000241	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NDUFV2—bipolar disorder	1.64e-05	0.000239	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—DRD2—bipolar disorder	1.64e-05	0.000239	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD1—bipolar disorder	1.63e-05	0.000237	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	1.63e-05	0.000237	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—SNAP25—bipolar disorder	1.62e-05	0.000236	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CLOCK—bipolar disorder	1.61e-05	0.000234	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CACNA1C—bipolar disorder	1.6e-05	0.000233	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—AKR1C4—bipolar disorder	1.59e-05	0.000232	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	1.58e-05	0.00023	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD3—bipolar disorder	1.58e-05	0.000229	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CLOCK—bipolar disorder	1.57e-05	0.000229	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	1.57e-05	0.000228	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—TPH2—bipolar disorder	1.57e-05	0.000228	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—TSHB—bipolar disorder	1.57e-05	0.000228	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CACNB2—bipolar disorder	1.57e-05	0.000228	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PIK3C2A—bipolar disorder	1.56e-05	0.000227	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—POMC—bipolar disorder	1.55e-05	0.000226	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—DPYD—bipolar disorder	1.54e-05	0.000225	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.54e-05	0.000224	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—TSHB—bipolar disorder	1.53e-05	0.000223	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—TPH2—bipolar disorder	1.53e-05	0.000223	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CACNB2—bipolar disorder	1.53e-05	0.000223	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD4—bipolar disorder	1.53e-05	0.000223	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—DPYD—bipolar disorder	1.51e-05	0.000219	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	1.49e-05	0.000216	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	1.49e-05	0.000216	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.48e-05	0.000216	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ADCY2—bipolar disorder	1.47e-05	0.000214	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CLOCK—bipolar disorder	1.47e-05	0.000214	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—S100B—bipolar disorder	1.44e-05	0.00021	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—TSHB—bipolar disorder	1.44e-05	0.00021	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—TPH2—bipolar disorder	1.44e-05	0.00021	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.44e-05	0.00021	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	1.44e-05	0.00021	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ADCY2—bipolar disorder	1.44e-05	0.000209	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	1.43e-05	0.000209	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CACNA1C—bipolar disorder	1.43e-05	0.000209	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—TSHB—bipolar disorder	1.43e-05	0.000208	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—TPH2—bipolar disorder	1.43e-05	0.000208	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CACNB2—bipolar disorder	1.43e-05	0.000208	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.43e-05	0.000208	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD2—bipolar disorder	1.42e-05	0.000208	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—DPYD—bipolar disorder	1.42e-05	0.000207	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—DPYD—bipolar disorder	1.41e-05	0.000205	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CACNA1C—bipolar disorder	1.4e-05	0.000204	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	1.4e-05	0.000204	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—SNAP25—bipolar disorder	1.4e-05	0.000203	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.38e-05	0.000201	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NCAN—bipolar disorder	1.37e-05	0.000199	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PIK3C2A—bipolar disorder	1.36e-05	0.000199	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—POMC—bipolar disorder	1.35e-05	0.000196	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.34e-05	0.000195	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.32e-05	0.000192	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CACNA1C—bipolar disorder	1.31e-05	0.000191	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	1.29e-05	0.000188	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.29e-05	0.000187	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	1.27e-05	0.000186	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NRG1—bipolar disorder	1.27e-05	0.000186	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.26e-05	0.000183	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—COMT—bipolar disorder	1.26e-05	0.000183	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CLOCK—bipolar disorder	1.25e-05	0.000183	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—S100B—bipolar disorder	1.25e-05	0.000183	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—SNAP25—bipolar disorder	1.25e-05	0.000183	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—MAOA—bipolar disorder	1.25e-05	0.000182	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ADCY2—bipolar disorder	1.24e-05	0.00018	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—COMT—bipolar disorder	1.23e-05	0.000179	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—SNAP25—bipolar disorder	1.22e-05	0.000178	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—TSHB—bipolar disorder	1.22e-05	0.000178	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—TPH2—bipolar disorder	1.22e-05	0.000178	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CACNB2—bipolar disorder	1.22e-05	0.000178	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—MAOA—bipolar disorder	1.22e-05	0.000178	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—DPYD—bipolar disorder	1.2e-05	0.000175	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.15e-05	0.000168	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	1.15e-05	0.000167	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—SNAP25—bipolar disorder	1.14e-05	0.000167	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CACNA1C—bipolar disorder	1.12e-05	0.000163	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADCY2—bipolar disorder	1.11e-05	0.000162	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NRG1—bipolar disorder	1.11e-05	0.000161	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	1.09e-05	0.000159	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADCY2—bipolar disorder	1.08e-05	0.000158	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.07e-05	0.000157	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—COMT—bipolar disorder	1.06e-05	0.000154	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MAOA—bipolar disorder	1.05e-05	0.000153	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.02e-05	0.000149	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—MTHFR—bipolar disorder	1.02e-05	0.000148	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADCY2—bipolar disorder	1.01e-05	0.000147	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—MTHFR—bipolar disorder	9.93e-06	0.000145	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—SNAP25—bipolar disorder	9.77e-06	0.000142	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CLOCK—bipolar disorder	9.68e-06	0.000141	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—COMT—bipolar disorder	9.5e-06	0.000138	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MAOA—bipolar disorder	9.43e-06	0.000137	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—TPH2—bipolar disorder	9.43e-06	0.000137	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—TSHB—bipolar disorder	9.43e-06	0.000137	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CACNB2—bipolar disorder	9.43e-06	0.000137	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—DPYD—bipolar disorder	9.28e-06	0.000135	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—COMT—bipolar disorder	9.27e-06	0.000135	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	9.25e-06	0.000135	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MAOA—bipolar disorder	9.21e-06	0.000134	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—POMC—bipolar disorder	9.18e-06	0.000134	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—INS—bipolar disorder	9.13e-06	0.000133	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—COMT—bipolar disorder	8.74e-06	0.000127	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MAOA—bipolar disorder	8.68e-06	0.000126	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—COMT—bipolar disorder	8.66e-06	0.000126	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADCY2—bipolar disorder	8.65e-06	0.000126	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CACNA1C—bipolar disorder	8.63e-06	0.000126	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MAOA—bipolar disorder	8.6e-06	0.000125	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MTHFR—bipolar disorder	8.56e-06	0.000125	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	8.41e-06	0.000122	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—POMC—bipolar disorder	8.13e-06	0.000118	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—INS—bipolar disorder	8.08e-06	0.000118	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	8.03e-06	0.000117	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—POMC—bipolar disorder	7.97e-06	0.000116	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—POMC—bipolar disorder	7.95e-06	0.000116	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—INS—bipolar disorder	7.92e-06	0.000115	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—INS—bipolar disorder	7.9e-06	0.000115	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MTHFR—bipolar disorder	7.68e-06	0.000112	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SNAP25—bipolar disorder	7.54e-06	0.00011	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MTHFR—bipolar disorder	7.5e-06	0.000109	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—COMT—bipolar disorder	7.4e-06	0.000108	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MAOA—bipolar disorder	7.35e-06	0.000107	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MTHFR—bipolar disorder	7.06e-06	0.000103	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MTHFR—bipolar disorder	7e-06	0.000102	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—POMC—bipolar disorder	6.84e-06	9.97e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—INS—bipolar disorder	6.8e-06	9.91e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADCY2—bipolar disorder	6.67e-06	9.72e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—POMC—bipolar disorder	6.14e-06	8.95e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—INS—bipolar disorder	6.11e-06	8.9e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—POMC—bipolar disorder	6e-06	8.73e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MTHFR—bipolar disorder	5.98e-06	8.72e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—INS—bipolar disorder	5.96e-06	8.68e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—COMT—bipolar disorder	5.71e-06	8.32e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MAOA—bipolar disorder	5.67e-06	8.26e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—POMC—bipolar disorder	5.65e-06	8.23e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—INS—bipolar disorder	5.62e-06	8.18e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—POMC—bipolar disorder	5.6e-06	8.16e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—INS—bipolar disorder	5.57e-06	8.11e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—POMC—bipolar disorder	4.79e-06	6.97e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—INS—bipolar disorder	4.76e-06	6.93e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MTHFR—bipolar disorder	4.62e-06	6.73e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—POMC—bipolar disorder	3.69e-06	5.38e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—INS—bipolar disorder	3.67e-06	5.35e-05	CbGpPWpGaD
